nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Mechlorethamine—lymphatic system cancer	0.517	0.591	CiPCiCtD
Thiotepa—Alkylating Activity—Carmustine—lymphatic system cancer	0.359	0.409	CiPCiCtD
Thiotepa—CYP3A4—Cytarabine—lymphatic system cancer	0.0105	0.318	CbGbCtD
Thiotepa—CYP3A4—Teniposide—lymphatic system cancer	0.0103	0.313	CbGbCtD
Thiotepa—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00724	0.219	CbGbCtD
Thiotepa—CYP3A4—Vincristine—lymphatic system cancer	0.00498	0.151	CbGbCtD
Thiotepa—Paraesthesia—Fludarabine—lymphatic system cancer	0.000111	0.00123	CcSEcCtD
Thiotepa—Hallucination—Carmustine—lymphatic system cancer	0.000111	0.00122	CcSEcCtD
Thiotepa—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000111	0.00122	CcSEcCtD
Thiotepa—Haematuria—Mitoxantrone—lymphatic system cancer	0.00011	0.00122	CcSEcCtD
Thiotepa—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00011	0.00121	CcSEcCtD
Thiotepa—Dyspepsia—Fludarabine—lymphatic system cancer	0.000109	0.0012	CcSEcCtD
Thiotepa—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000108	0.00119	CcSEcCtD
Thiotepa—Decreased appetite—Fludarabine—lymphatic system cancer	0.000108	0.00119	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000107	0.00118	CcSEcCtD
Thiotepa—Fatigue—Fludarabine—lymphatic system cancer	0.000107	0.00118	CcSEcCtD
Thiotepa—Hallucination—Vincristine—lymphatic system cancer	0.000106	0.00117	CcSEcCtD
Thiotepa—Pain—Fludarabine—lymphatic system cancer	0.000106	0.00117	CcSEcCtD
Thiotepa—Constipation—Fludarabine—lymphatic system cancer	0.000106	0.00117	CcSEcCtD
Thiotepa—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000105	0.00116	CcSEcCtD
Thiotepa—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.000105	0.00116	CcSEcCtD
Thiotepa—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000105	0.00115	CcSEcCtD
Thiotepa—Urethral disorder—Vincristine—lymphatic system cancer	0.000105	0.00115	CcSEcCtD
Thiotepa—Eye disorder—Carmustine—lymphatic system cancer	0.000104	0.00115	CcSEcCtD
Thiotepa—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000104	0.00115	CcSEcCtD
Thiotepa—Hypersensitivity—Teniposide—lymphatic system cancer	0.000104	0.00115	CcSEcCtD
Thiotepa—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000104	0.00114	CcSEcCtD
Thiotepa—Anaemia—Bleomycin—lymphatic system cancer	0.000103	0.00113	CcSEcCtD
Thiotepa—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000102	0.00113	CcSEcCtD
Thiotepa—Asthenia—Teniposide—lymphatic system cancer	0.000101	0.00112	CcSEcCtD
Thiotepa—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000101	0.00111	CcSEcCtD
Thiotepa—Pruritus—Teniposide—lymphatic system cancer	9.99e-05	0.0011	CcSEcCtD
Thiotepa—Arrhythmia—Carmustine—lymphatic system cancer	9.98e-05	0.0011	CcSEcCtD
Thiotepa—Leukopenia—Bleomycin—lymphatic system cancer	9.98e-05	0.0011	CcSEcCtD
Thiotepa—Cystitis—Methotrexate—lymphatic system cancer	9.95e-05	0.0011	CcSEcCtD
Thiotepa—Cardiac disorder—Vincristine—lymphatic system cancer	9.9e-05	0.00109	CcSEcCtD
Thiotepa—Alopecia—Carmustine—lymphatic system cancer	9.88e-05	0.00109	CcSEcCtD
Thiotepa—Skin exfoliation—Methotrexate—lymphatic system cancer	9.84e-05	0.00108	CcSEcCtD
Thiotepa—Body temperature increased—Fludarabine—lymphatic system cancer	9.81e-05	0.00108	CcSEcCtD
Thiotepa—Mental disorder—Carmustine—lymphatic system cancer	9.79e-05	0.00108	CcSEcCtD
Thiotepa—Malnutrition—Carmustine—lymphatic system cancer	9.73e-05	0.00107	CcSEcCtD
Thiotepa—Erythema—Carmustine—lymphatic system cancer	9.73e-05	0.00107	CcSEcCtD
Thiotepa—Cough—Bleomycin—lymphatic system cancer	9.73e-05	0.00107	CcSEcCtD
Thiotepa—Angiopathy—Vincristine—lymphatic system cancer	9.68e-05	0.00107	CcSEcCtD
Thiotepa—Diarrhoea—Teniposide—lymphatic system cancer	9.66e-05	0.00106	CcSEcCtD
Thiotepa—Mediastinal disorder—Vincristine—lymphatic system cancer	9.62e-05	0.00106	CcSEcCtD
Thiotepa—Myalgia—Bleomycin—lymphatic system cancer	9.49e-05	0.00105	CcSEcCtD
Thiotepa—Alopecia—Vincristine—lymphatic system cancer	9.43e-05	0.00104	CcSEcCtD
Thiotepa—Back pain—Carmustine—lymphatic system cancer	9.41e-05	0.00104	CcSEcCtD
Thiotepa—Mental disorder—Vincristine—lymphatic system cancer	9.35e-05	0.00103	CcSEcCtD
Thiotepa—Chills—Mitoxantrone—lymphatic system cancer	9.32e-05	0.00103	CcSEcCtD
Thiotepa—Bladder pain—Methotrexate—lymphatic system cancer	9.32e-05	0.00103	CcSEcCtD
Thiotepa—Arrhythmia—Mitoxantrone—lymphatic system cancer	9.28e-05	0.00102	CcSEcCtD
Thiotepa—Alopecia—Mitoxantrone—lymphatic system cancer	9.18e-05	0.00101	CcSEcCtD
Thiotepa—Pulmonary oedema—Methotrexate—lymphatic system cancer	9.18e-05	0.00101	CcSEcCtD
Thiotepa—Confusional state—Bleomycin—lymphatic system cancer	9.17e-05	0.00101	CcSEcCtD
Thiotepa—Vision blurred—Carmustine—lymphatic system cancer	9.17e-05	0.00101	CcSEcCtD
Thiotepa—Hypersensitivity—Fludarabine—lymphatic system cancer	9.14e-05	0.00101	CcSEcCtD
Thiotepa—Erythema—Mitoxantrone—lymphatic system cancer	9.05e-05	0.000996	CcSEcCtD
Thiotepa—Infection—Bleomycin—lymphatic system cancer	9.04e-05	0.000995	CcSEcCtD
Thiotepa—Anaemia—Carmustine—lymphatic system cancer	8.99e-05	0.00099	CcSEcCtD
Thiotepa—Back pain—Vincristine—lymphatic system cancer	8.98e-05	0.00099	CcSEcCtD
Thiotepa—Vomiting—Teniposide—lymphatic system cancer	8.98e-05	0.000989	CcSEcCtD
Thiotepa—Sepsis—Methotrexate—lymphatic system cancer	8.95e-05	0.000985	CcSEcCtD
Thiotepa—Agitation—Carmustine—lymphatic system cancer	8.94e-05	0.000985	CcSEcCtD
Thiotepa—Thrombocytopenia—Bleomycin—lymphatic system cancer	8.91e-05	0.000981	CcSEcCtD
Thiotepa—Asthenia—Fludarabine—lymphatic system cancer	8.9e-05	0.00098	CcSEcCtD
Thiotepa—Rash—Teniposide—lymphatic system cancer	8.9e-05	0.00098	CcSEcCtD
Thiotepa—Dermatitis—Teniposide—lymphatic system cancer	8.89e-05	0.000979	CcSEcCtD
Thiotepa—Headache—Teniposide—lymphatic system cancer	8.84e-05	0.000974	CcSEcCtD
Thiotepa—Pruritus—Fludarabine—lymphatic system cancer	8.78e-05	0.000967	CcSEcCtD
Thiotepa—Back pain—Mitoxantrone—lymphatic system cancer	8.75e-05	0.000964	CcSEcCtD
Thiotepa—Leukopenia—Carmustine—lymphatic system cancer	8.71e-05	0.000959	CcSEcCtD
Thiotepa—Anorexia—Bleomycin—lymphatic system cancer	8.67e-05	0.000955	CcSEcCtD
Thiotepa—Anaemia—Vincristine—lymphatic system cancer	8.58e-05	0.000946	CcSEcCtD
Thiotepa—Agitation—Vincristine—lymphatic system cancer	8.54e-05	0.00094	CcSEcCtD
Thiotepa—Vision blurred—Mitoxantrone—lymphatic system cancer	8.52e-05	0.000939	CcSEcCtD
Thiotepa—Diarrhoea—Fludarabine—lymphatic system cancer	8.49e-05	0.000935	CcSEcCtD
Thiotepa—Convulsion—Carmustine—lymphatic system cancer	8.43e-05	0.000928	CcSEcCtD
Thiotepa—Hypertension—Carmustine—lymphatic system cancer	8.4e-05	0.000925	CcSEcCtD
Thiotepa—Nausea—Teniposide—lymphatic system cancer	8.39e-05	0.000924	CcSEcCtD
Thiotepa—Anaemia—Mitoxantrone—lymphatic system cancer	8.36e-05	0.000921	CcSEcCtD
Thiotepa—Hepatic failure—Methotrexate—lymphatic system cancer	8.33e-05	0.000917	CcSEcCtD
Thiotepa—Leukopenia—Vincristine—lymphatic system cancer	8.31e-05	0.000916	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	8.29e-05	0.000913	CcSEcCtD
Thiotepa—Myalgia—Carmustine—lymphatic system cancer	8.28e-05	0.000912	CcSEcCtD
Thiotepa—Anxiety—Carmustine—lymphatic system cancer	8.25e-05	0.000909	CcSEcCtD
Thiotepa—Paraesthesia—Bleomycin—lymphatic system cancer	8.17e-05	0.0009	CcSEcCtD
Thiotepa—Leukopenia—Mitoxantrone—lymphatic system cancer	8.1e-05	0.000892	CcSEcCtD
Thiotepa—Convulsion—Vincristine—lymphatic system cancer	8.05e-05	0.000886	CcSEcCtD
Thiotepa—Hypertension—Vincristine—lymphatic system cancer	8.02e-05	0.000883	CcSEcCtD
Thiotepa—Confusional state—Carmustine—lymphatic system cancer	8.01e-05	0.000882	CcSEcCtD
Thiotepa—Decreased appetite—Bleomycin—lymphatic system cancer	7.91e-05	0.000871	CcSEcCtD
Thiotepa—Myalgia—Vincristine—lymphatic system cancer	7.91e-05	0.000871	CcSEcCtD
Thiotepa—Cough—Mitoxantrone—lymphatic system cancer	7.89e-05	0.000869	CcSEcCtD
Thiotepa—Infection—Carmustine—lymphatic system cancer	7.89e-05	0.000869	CcSEcCtD
Thiotepa—Vomiting—Fludarabine—lymphatic system cancer	7.89e-05	0.000869	CcSEcCtD
Thiotepa—Convulsion—Mitoxantrone—lymphatic system cancer	7.84e-05	0.000863	CcSEcCtD
Thiotepa—Rash—Fludarabine—lymphatic system cancer	7.82e-05	0.000862	CcSEcCtD
Thiotepa—Dermatitis—Fludarabine—lymphatic system cancer	7.82e-05	0.000861	CcSEcCtD
Thiotepa—Hypertension—Mitoxantrone—lymphatic system cancer	7.81e-05	0.00086	CcSEcCtD
Thiotepa—Pain—Bleomycin—lymphatic system cancer	7.78e-05	0.000857	CcSEcCtD
Thiotepa—Thrombocytopenia—Carmustine—lymphatic system cancer	7.77e-05	0.000856	CcSEcCtD
Thiotepa—Headache—Fludarabine—lymphatic system cancer	7.77e-05	0.000856	CcSEcCtD
Thiotepa—Tachycardia—Carmustine—lymphatic system cancer	7.75e-05	0.000854	CcSEcCtD
Thiotepa—Arthralgia—Mitoxantrone—lymphatic system cancer	7.7e-05	0.000848	CcSEcCtD
Thiotepa—Myalgia—Mitoxantrone—lymphatic system cancer	7.7e-05	0.000848	CcSEcCtD
Thiotepa—Anxiety—Mitoxantrone—lymphatic system cancer	7.67e-05	0.000845	CcSEcCtD
Thiotepa—Anorexia—Carmustine—lymphatic system cancer	7.57e-05	0.000834	CcSEcCtD
Thiotepa—Infection—Vincristine—lymphatic system cancer	7.53e-05	0.000829	CcSEcCtD
Thiotepa—Feeling abnormal—Bleomycin—lymphatic system cancer	7.5e-05	0.000826	CcSEcCtD
Thiotepa—Confusional state—Mitoxantrone—lymphatic system cancer	7.44e-05	0.00082	CcSEcCtD
Thiotepa—Nervous system disorder—Vincristine—lymphatic system cancer	7.43e-05	0.000819	CcSEcCtD
Thiotepa—Thrombocytopenia—Vincristine—lymphatic system cancer	7.42e-05	0.000817	CcSEcCtD
Thiotepa—Nausea—Fludarabine—lymphatic system cancer	7.37e-05	0.000812	CcSEcCtD
Thiotepa—Infection—Mitoxantrone—lymphatic system cancer	7.33e-05	0.000808	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	7.23e-05	0.000797	CcSEcCtD
Thiotepa—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	7.23e-05	0.000796	CcSEcCtD
Thiotepa—Urticaria—Bleomycin—lymphatic system cancer	7.23e-05	0.000796	CcSEcCtD
Thiotepa—Anorexia—Vincristine—lymphatic system cancer	7.23e-05	0.000796	CcSEcCtD
Thiotepa—Tachycardia—Mitoxantrone—lymphatic system cancer	7.21e-05	0.000794	CcSEcCtD
Thiotepa—Body temperature increased—Bleomycin—lymphatic system cancer	7.19e-05	0.000792	CcSEcCtD
Thiotepa—Skin disorder—Mitoxantrone—lymphatic system cancer	7.17e-05	0.00079	CcSEcCtD
Thiotepa—Paraesthesia—Carmustine—lymphatic system cancer	7.13e-05	0.000785	CcSEcCtD
Thiotepa—Somnolence—Carmustine—lymphatic system cancer	7.06e-05	0.000778	CcSEcCtD
Thiotepa—Anorexia—Mitoxantrone—lymphatic system cancer	7.04e-05	0.000775	CcSEcCtD
Thiotepa—Ataxia—Methotrexate—lymphatic system cancer	7.04e-05	0.000775	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	6.91e-05	0.000761	CcSEcCtD
Thiotepa—Decreased appetite—Carmustine—lymphatic system cancer	6.9e-05	0.00076	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Carmustine—lymphatic system cancer	6.86e-05	0.000755	CcSEcCtD
Thiotepa—Paraesthesia—Vincristine—lymphatic system cancer	6.81e-05	0.00075	CcSEcCtD
Thiotepa—Pain—Carmustine—lymphatic system cancer	6.79e-05	0.000748	CcSEcCtD
Thiotepa—Constipation—Carmustine—lymphatic system cancer	6.79e-05	0.000748	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	6.73e-05	0.000741	CcSEcCtD
Thiotepa—Hypersensitivity—Bleomycin—lymphatic system cancer	6.7e-05	0.000738	CcSEcCtD
Thiotepa—Paraesthesia—Mitoxantrone—lymphatic system cancer	6.63e-05	0.00073	CcSEcCtD
Thiotepa—Decreased appetite—Vincristine—lymphatic system cancer	6.59e-05	0.000726	CcSEcCtD
Thiotepa—Somnolence—Mitoxantrone—lymphatic system cancer	6.56e-05	0.000723	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Vincristine—lymphatic system cancer	6.54e-05	0.000721	CcSEcCtD
Thiotepa—Feeling abnormal—Carmustine—lymphatic system cancer	6.54e-05	0.000721	CcSEcCtD
Thiotepa—Fatigue—Vincristine—lymphatic system cancer	6.54e-05	0.00072	CcSEcCtD
Thiotepa—Asthenia—Bleomycin—lymphatic system cancer	6.53e-05	0.000719	CcSEcCtD
Thiotepa—Dyspepsia—Mitoxantrone—lymphatic system cancer	6.5e-05	0.000716	CcSEcCtD
Thiotepa—Gastrointestinal pain—Carmustine—lymphatic system cancer	6.49e-05	0.000715	CcSEcCtD
Thiotepa—Pain—Vincristine—lymphatic system cancer	6.48e-05	0.000714	CcSEcCtD
Thiotepa—Constipation—Vincristine—lymphatic system cancer	6.48e-05	0.000714	CcSEcCtD
Thiotepa—Pruritus—Bleomycin—lymphatic system cancer	6.44e-05	0.000709	CcSEcCtD
Thiotepa—Decreased appetite—Mitoxantrone—lymphatic system cancer	6.42e-05	0.000707	CcSEcCtD
Thiotepa—Fatigue—Mitoxantrone—lymphatic system cancer	6.36e-05	0.000701	CcSEcCtD
Thiotepa—Pain—Mitoxantrone—lymphatic system cancer	6.31e-05	0.000695	CcSEcCtD
Thiotepa—Constipation—Mitoxantrone—lymphatic system cancer	6.31e-05	0.000695	CcSEcCtD
Thiotepa—Body temperature increased—Carmustine—lymphatic system cancer	6.28e-05	0.000691	CcSEcCtD
Thiotepa—Abdominal pain—Carmustine—lymphatic system cancer	6.28e-05	0.000691	CcSEcCtD
Thiotepa—Gastrointestinal pain—Vincristine—lymphatic system cancer	6.2e-05	0.000683	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—lymphatic system cancer	6.14e-05	0.000677	CcSEcCtD
Thiotepa—Feeling abnormal—Mitoxantrone—lymphatic system cancer	6.08e-05	0.00067	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—lymphatic system cancer	6.05e-05	0.000666	CcSEcCtD
Thiotepa—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	6.04e-05	0.000665	CcSEcCtD
Thiotepa—Body temperature increased—Vincristine—lymphatic system cancer	5.99e-05	0.00066	CcSEcCtD
Thiotepa—Abdominal pain—Vincristine—lymphatic system cancer	5.99e-05	0.00066	CcSEcCtD
Thiotepa—Urticaria—Mitoxantrone—lymphatic system cancer	5.86e-05	0.000646	CcSEcCtD
Thiotepa—Hypersensitivity—Carmustine—lymphatic system cancer	5.85e-05	0.000644	CcSEcCtD
Thiotepa—Body temperature increased—Mitoxantrone—lymphatic system cancer	5.84e-05	0.000643	CcSEcCtD
Thiotepa—Abdominal pain—Mitoxantrone—lymphatic system cancer	5.84e-05	0.000643	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—lymphatic system cancer	5.8e-05	0.000639	CcSEcCtD
Thiotepa—Vomiting—Bleomycin—lymphatic system cancer	5.78e-05	0.000637	CcSEcCtD
Thiotepa—Infestation—Methotrexate—lymphatic system cancer	5.77e-05	0.000635	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—lymphatic system cancer	5.77e-05	0.000635	CcSEcCtD
Thiotepa—Rash—Bleomycin—lymphatic system cancer	5.74e-05	0.000632	CcSEcCtD
Thiotepa—Dermatitis—Bleomycin—lymphatic system cancer	5.73e-05	0.000631	CcSEcCtD
Thiotepa—Asthenia—Carmustine—lymphatic system cancer	5.7e-05	0.000628	CcSEcCtD
Thiotepa—Renal failure—Methotrexate—lymphatic system cancer	5.67e-05	0.000624	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—lymphatic system cancer	5.62e-05	0.000619	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—lymphatic system cancer	5.61e-05	0.000617	CcSEcCtD
Thiotepa—Hypersensitivity—Vincristine—lymphatic system cancer	5.58e-05	0.000615	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—lymphatic system cancer	5.5e-05	0.000606	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—lymphatic system cancer	5.45e-05	0.000601	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—lymphatic system cancer	5.44e-05	0.000599	CcSEcCtD
Thiotepa—Hypersensitivity—Mitoxantrone—lymphatic system cancer	5.44e-05	0.000599	CcSEcCtD
Thiotepa—Asthenia—Vincristine—lymphatic system cancer	5.44e-05	0.000599	CcSEcCtD
Thiotepa—Diarrhoea—Carmustine—lymphatic system cancer	5.43e-05	0.000598	CcSEcCtD
Thiotepa—Nausea—Bleomycin—lymphatic system cancer	5.4e-05	0.000595	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—lymphatic system cancer	5.38e-05	0.000593	CcSEcCtD
Thiotepa—Asthenia—Mitoxantrone—lymphatic system cancer	5.3e-05	0.000583	CcSEcCtD
Thiotepa—Dizziness—Carmustine—lymphatic system cancer	5.25e-05	0.000578	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—lymphatic system cancer	5.2e-05	0.000573	CcSEcCtD
Thiotepa—Diarrhoea—Vincristine—lymphatic system cancer	5.19e-05	0.000571	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—lymphatic system cancer	5.18e-05	0.00057	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—lymphatic system cancer	5.11e-05	0.000563	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—lymphatic system cancer	5.07e-05	0.000559	CcSEcCtD
Thiotepa—Diarrhoea—Mitoxantrone—lymphatic system cancer	5.05e-05	0.000556	CcSEcCtD
Thiotepa—Vomiting—Carmustine—lymphatic system cancer	5.05e-05	0.000556	CcSEcCtD
Thiotepa—Dizziness—Vincristine—lymphatic system cancer	5.01e-05	0.000552	CcSEcCtD
Thiotepa—Rash—Carmustine—lymphatic system cancer	5.01e-05	0.000551	CcSEcCtD
Thiotepa—Dermatitis—Carmustine—lymphatic system cancer	5e-05	0.000551	CcSEcCtD
Thiotepa—Headache—Carmustine—lymphatic system cancer	4.97e-05	0.000548	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—lymphatic system cancer	4.84e-05	0.000533	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—lymphatic system cancer	4.83e-05	0.000532	CcSEcCtD
Thiotepa—Vomiting—Vincristine—lymphatic system cancer	4.82e-05	0.000531	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—lymphatic system cancer	4.8e-05	0.000529	CcSEcCtD
Thiotepa—Rash—Vincristine—lymphatic system cancer	4.78e-05	0.000526	CcSEcCtD
Thiotepa—Dermatitis—Vincristine—lymphatic system cancer	4.78e-05	0.000526	CcSEcCtD
Thiotepa—Headache—Vincristine—lymphatic system cancer	4.75e-05	0.000523	CcSEcCtD
Thiotepa—Nausea—Carmustine—lymphatic system cancer	4.72e-05	0.00052	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—lymphatic system cancer	4.7e-05	0.000517	CcSEcCtD
Thiotepa—Vomiting—Mitoxantrone—lymphatic system cancer	4.69e-05	0.000517	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—lymphatic system cancer	4.68e-05	0.000515	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—lymphatic system cancer	4.67e-05	0.000514	CcSEcCtD
Thiotepa—Rash—Mitoxantrone—lymphatic system cancer	4.65e-05	0.000513	CcSEcCtD
Thiotepa—Dermatitis—Mitoxantrone—lymphatic system cancer	4.65e-05	0.000512	CcSEcCtD
Thiotepa—Chills—Methotrexate—lymphatic system cancer	4.65e-05	0.000512	CcSEcCtD
Thiotepa—Headache—Mitoxantrone—lymphatic system cancer	4.62e-05	0.000509	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—lymphatic system cancer	4.57e-05	0.000504	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—lymphatic system cancer	4.54e-05	0.0005	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—lymphatic system cancer	4.51e-05	0.000496	CcSEcCtD
Thiotepa—Erythema—Methotrexate—lymphatic system cancer	4.51e-05	0.000496	CcSEcCtD
Thiotepa—Nausea—Vincristine—lymphatic system cancer	4.5e-05	0.000496	CcSEcCtD
Thiotepa—Nausea—Mitoxantrone—lymphatic system cancer	4.39e-05	0.000483	CcSEcCtD
Thiotepa—Back pain—Methotrexate—lymphatic system cancer	4.36e-05	0.00048	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—lymphatic system cancer	4.25e-05	0.000468	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—lymphatic system cancer	4.17e-05	0.000459	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—lymphatic system cancer	4.03e-05	0.000444	CcSEcCtD
Thiotepa—Cough—Methotrexate—lymphatic system cancer	3.93e-05	0.000433	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—lymphatic system cancer	3.9e-05	0.00043	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—lymphatic system cancer	3.84e-05	0.000423	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—lymphatic system cancer	3.84e-05	0.000423	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	3.81e-05	0.00042	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—lymphatic system cancer	3.71e-05	0.000408	CcSEcCtD
Thiotepa—Infection—Methotrexate—lymphatic system cancer	3.65e-05	0.000402	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—lymphatic system cancer	3.61e-05	0.000397	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—lymphatic system cancer	3.6e-05	0.000397	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—lymphatic system cancer	3.57e-05	0.000393	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—lymphatic system cancer	3.51e-05	0.000386	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	3.35e-05	0.000369	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—lymphatic system cancer	3.3e-05	0.000364	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—lymphatic system cancer	3.27e-05	0.00036	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—lymphatic system cancer	3.24e-05	0.000357	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—lymphatic system cancer	3.2e-05	0.000352	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	3.18e-05	0.00035	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—lymphatic system cancer	3.17e-05	0.000349	CcSEcCtD
Thiotepa—Pain—Methotrexate—lymphatic system cancer	3.15e-05	0.000346	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—lymphatic system cancer	3.03e-05	0.000334	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—lymphatic system cancer	3.01e-05	0.000331	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—lymphatic system cancer	2.92e-05	0.000322	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—lymphatic system cancer	2.91e-05	0.00032	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—lymphatic system cancer	2.91e-05	0.00032	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—lymphatic system cancer	2.71e-05	0.000298	CcSEcCtD
Thiotepa—Asthenia—Methotrexate—lymphatic system cancer	2.64e-05	0.000291	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—lymphatic system cancer	2.6e-05	0.000287	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—lymphatic system cancer	2.52e-05	0.000277	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—lymphatic system cancer	2.43e-05	0.000268	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—lymphatic system cancer	2.34e-05	0.000258	CcSEcCtD
Thiotepa—Rash—Methotrexate—lymphatic system cancer	2.32e-05	0.000255	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—lymphatic system cancer	2.32e-05	0.000255	CcSEcCtD
Thiotepa—Headache—Methotrexate—lymphatic system cancer	2.3e-05	0.000254	CcSEcCtD
Thiotepa—Nausea—Methotrexate—lymphatic system cancer	2.18e-05	0.000241	CcSEcCtD
